Epidemiology and reporting of candidaemia in Belgium: a multi-centre study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 4, 2017, Pages 649-655

  Trouve C ^a   Blot, S ^b,c   Hayette, M P ^d   Jonckheere, S ^e   Patteet, S ^a   Rodriguez Villalobos, H ^f   Symoens, F ^g   Van Wijngaerden, E ^a   Lagrou, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e Jan Yperman Hospital   (Belgium)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL RESISTANCE; ARTICLE; BELGIUM; CANDIDA ALBICANS; CANDIDA FERMENTATI; CANDIDA GLABRATA; CANDIDA METAPSILOSIS; CANDIDA PALMIOLEOPHILA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTICENTER STUDY; PICHIA KUDRIAVZEVII; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPECIES IDENTIFICATION; CANDIDA; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC TEST; DNA SEQUENCE; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PRESCHOOL CHILD; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BELGIUM; CANDIDA; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; DRUG RESISTANCE, FUNGAL; FEMALE; HOSPITALS; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; YOUNG ADULT;

EID: 84995783978     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2841-3     Document Type: Article

References (29)

1. Vallabhaneni S, Mody RK, Walker T, Chiller T (2016) The global burden of fungal diseases. Infect Dis Clin North Am 30:1–11
2. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R; ECMM Working Group on Candidaemia (2004) Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317–322
3. Caggiano G, Coretti C, Bartolomeo N, Lovero G, De Giglio O, Montagna MT (2015) Candida bloodstream infections in Italy: changing epidemiology during 16 years of surveillance. Biomed Res Int. doi:10.1155/2015/256580
4. Ericsson J, Chryssanthou E, Klingspor L, Johansson AG, Ljungman P, Svensson E, Sjölin J (2013) Candidaemia in Sweden: a nationwide prospective observational survey. Clin Microbiol Infect 19(4):E218–E221
5. Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, Hermansen NO, Larssen KW, Mylvaganam H, Ranheim TE, Sandven P, Nordøy I; Norwegian Yeast Study Group, Kanestrøm A, Grub C, Onken A, Thielsen C, Skaare D, Tofteland S, Sønsteby LJ, Hjetland R, Hide R, Vik E, Kümmel A, Åsheim S (2015) Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect 10:938–945
6. Nieto MC, Tellería O, Cisterna R (2015) Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility. Diagn Microbiol Infect Dis 81:34–40
7. Guinea J, Zaragoza Ó, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, Cuenca-Estrella M; CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI (2014) Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother 58:1529–1537
8. Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R, Calandra T, Bille J (2014) Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Clin Microbiol Infect 7:698–705
9. Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F (2014) Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 20:1149–1155
10. Lagrou K, Verhaegen J, Peetermans WE, De Rijdt T, Maertens J, Van Wijngaerden E (2007) Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 26:541–547
11. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA; Global Antifungal Surveillance Group (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48:1366–1377
12. Arendrup MC (2014) Update on antifungal resistance in Aspergillus and Candida. Clin Microbiol Infect 20:42–48
13. Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M (2013) Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol 51:2571–2581
14. Arendrup MC, Perlin DS (2014) Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 27:484–492
15. Farmakiotis D, Tarrand JJ, Kontoyiannis DP (2014) Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis 20:1833–1840
16. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724–1732
17. Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG, Derado G, Pham CD, Lockhart SR, Smith RM (2015) Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008–2014. Open Forum Infect Dis 2(4):ofv163
18. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN (2012) Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 50:1199–1203
19. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18:19–37
20. van der Geest PJ, Rijnders BJ, Vonk AG, Groeneveld AB (2016) Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections. Mycoses 59:179–185
21. Pryce TM, Palladino S, Kay ID, Coombs GW (2003) Rapid identification of fungi by sequencing the ITS1 and ITS2 regions using an automated capillary electrophoresis system. Med Mycol 41:369–381
22. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antifungal Agents. Breakpoint tables for interpretation of MICs. Version 7.0, valid from 2014-08-12
23. Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, Lockhart SR, Park BJ (2015) Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance. PLoS One 10(3):e0120452
24. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T (2012) Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 50:3435–3442
25. Pfaller MA, Messer SA, Jones RN, Castanheira M (2015) Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012). J Antibiot (Tokyo) 68:556–561
26. Marcos-Zambrano LJ, Escribano P, Sánchez C, Muñoz P, Bouza E, Guinea J (2014) Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center. Antimicrob Agents Chemother 58:4565–4572
27. Huang L, Zhang YY, Sun LY (2013) Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia. Eur J Clin Microbiol Infect Dis 32:917–922
28. Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR (2004) Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J Clin Microbiol 42:115–118
29. Dixon P, Davies P, Hollingworth W, Stoddart M, MacGowan A (2015) A systematic review of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry compared to routine microbiological methods for the time taken to identify microbial organisms from positive blood cultures. Eur J Clin Microbiol Infect Dis 34:863–876